Abstract
ANALYSIS OF PHARMACOVIGILANCE DATA AT THE ADVERSE DRUG MONITORING CENTRE PERTAINING TO ANTI TUBERCULAR DRUGS -A RETROSPECTIVE CROSS-SECTIONAL STUDY

Dr. M. Nandhini Priya M.D., DTCD., *Dr. S. Anusha M.D.* and Dr. N. Shanthi M.D.

ABSTRACT

Background: The pharmacovigilance programme of India aims to improve patient safety and welfare of Indian population by identifying and analysing new signals from the reported cases and generating evidence based information on safety of medicines. The purpose of this study is to collect the data of adverse drug reactions to the antitubercular drugs and analyse them. India accounts for one fourth of global tuberculosis burden. In 2017, elimination of tuberculosis in India by 2025 was announced as a national goal. Antitubercular drugs are more prone to cause adverse drug reactions. This in turn may lead to poor compliance paving way for the development of drug resistance tuberculosis. Early detection and proper management minimizes this risk. The vision is to communicate the safety information to the health care professionals and public hence reducing the drug related complications. Methodology: This is a retrospective cross sectional study of adverse drug reactions reported to the adverse drug reactions monitoring centre regarding the antitubercular drugs. The data collected were from the CDSCO’s adverse drug reactions reporting form, reported in the time period of June 2015 – July 2017. Results: The demographic pattern, causality, severity of the adverse drug reactions were analysed. 187 adverse drug reactions were reported during the study period which included 133 men and 54 women. The mean age of the reported adverse drug reactions was 46.4±17.59 years. Among the antitubercular drugs pyrazinamide was more prone to cause adverse drug reactions followed by streptomycin. In 62.6% of cases the antitubercular drugs were the probable cause and in 37.4% of adverse reactions ATT were the possible cause. 91.4% of them were non serious and 8.6% of them were serious adverse drug reactions. Most common adverse drug reaction reported was dermatological reactions followed by gastrointestinal and neurological side effects. The study showed that there was a significant association between the causality and seriousness of the adverse reactions encountered. Conclusion: This study serves to stress the importance of pharmacovigilance programme, create awareness and intensify the ADR reporting by the health care workers. This is also useful in educating the drug related complications to the patients and the public.

Keywords: Adverse drug reactions, pharmacovigilance, antituberculosis drugs, causality, severity.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2020 Issue has been successfully launched on 1 February 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT